FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor

FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor

Submitted by admin on September 18, 2024 - 11:56am
Source: 
Clinical Trials Arena
News Tags: 
Zentalis Pharmaceuticals
azenosertib
FDA
clinical trials
Headline: 
FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor
snippet: 

The US Food and Drug Administration (FDA) has lifted a partial clinical hold on Zentalis Pharmaceuticals’ azenosertib, allowing the company to continue evaluating the drug as a treatment for cancer.  

Do Not Allow Advertisers to Use My Personal information